The 100 Most Influential People in Oncology in 2025 (Full List)
Jacobio Pharma and AstraZeneca Strike $2 B Deal for Pan‑KRAS Inhibitor
Jemma Arakelyan: Oncology Is Not Chosen for Work-Life Balance - It’s Chosen for Purpose
Become a Volunteer and Help Build the Global Directory of Oncologists
Sandrine Piret-Gerard: Closing a Meaningful 4-Year Chapter at Gilead Sciences
Joseph Grossman: Clinical Results of Botensilimab Plus Balstilimab in Treatment-Refractory Ovarian Cancer
Naveen Pemmaraju: Bringing More Global Awareness and a New International Collaboration for BPDCN
Can the European Biotech Act Make Europe a Global Biotech Leader?
